Consonance Capital Management as of Dec. 31, 2015
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 22 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eagle Pharmaceuticals (EGRX) | 16.7 | $125M | 1.4M | 88.67 | |
| Insys Therapeutics | 9.9 | $74M | 2.6M | 28.63 | |
| Orthofix International Nv Com Stk | 9.7 | $73M | 1.8M | 39.21 | |
| Pacific Biosciences of California (PACB) | 9.7 | $72M | 5.5M | 13.13 | |
| Akorn | 9.5 | $71M | 1.9M | 37.31 | |
| Retrophin | 8.9 | $67M | 3.5M | 19.29 | |
| Mallinckrodt Pub | 7.6 | $57M | 760k | 74.63 | |
| Lannett Company | 7.1 | $53M | 1.3M | 40.12 | |
| Abbvie (ABBV) | 6.2 | $46M | 778k | 59.24 | |
| Biosante Pharmaceuticals (ANIP) | 5.7 | $43M | 947k | 45.12 | |
| Osiris Therapeutics | 3.1 | $23M | 2.2M | 10.38 | |
| Vanda Pharmaceuticals (VNDA) | 1.4 | $10M | 1.1M | 9.31 | |
| Adma Biologics (ADMA) | 1.1 | $8.6M | 1.1M | 8.07 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.9 | $7.1M | 2.9M | 2.45 | |
| Vericel (VCEL) | 0.8 | $6.1M | 2.4M | 2.58 | |
| Derma Sciences | 0.6 | $4.3M | 938k | 4.57 | |
| Seaspine Holdings | 0.3 | $2.5M | 148k | 17.18 | |
| Axogen (AXGN) | 0.3 | $2.0M | 406k | 5.00 | |
| Veracyte (VCYT) | 0.2 | $1.2M | 166k | 7.20 | |
| Biolase Technology | 0.1 | $921k | 1.1M | 0.84 | |
| Cti Biopharma | 0.1 | $638k | 510k | 1.25 | |
| Merus Labs Intl | 0.0 | $47k | 29k | 1.65 |
